— Know what they know.
Not Investment Advice

GNOG.L

Global X - Genomics & Biotechnology UCITS ETF
1W: -0.5% 1M: +10.5% 3M: +19.2% YTD: +52.6% 1Y: +94.0% 3Y: +49.9%
£9.37 ($12.40)
-0.16 (-1.68%)
 
Weekly Expected Move ±3.9%
£9 £9 £9 £10 £10
ETF LSE · AUM £51.1M

Portfolio Health Summary

IS Overall Score
47.8
★★★★★
Altman Z-Score
12.15
Safe
Weight Coverage
100%
of portfolio analyzed
Holdings Matched
50
with fundamental data

InsiderStreet Scorecard

★★★★★ 47.8
Profitability
36.1
Balance Sheet
50.8
Earnings Quality
51.8
Growth
50.9
Value
35.8
Momentum
58.0
Safety
87.6

Top Holdings: Score Breakdown

Risk & Quality Signals

Altman Z-Score
12.15
Safe Zone (>2.99)
Piotroski F-Score
4.7 / 9
Moderate
Beneish M-Score
-1.07
Possible Manipulator
Credit Score
—
Earnings Quality
51.8 / 100

Portfolio Valuation

P/E
51.25x
P/B
10.68x
P/S
10.81x
EV/EBITDA
34.84x
EV/Revenue
10.51x
P/FCF
49.05x
P/OCF
39.08x
PEG
6.78x
Earnings Yield
1.95%
FCF Yield
2.04%
OCF Yield
2.56%
Median P/E
-4.75x

Growth & Shareholder Returns

Year-over-Year Growth

Revenue +12.4%
Net Income +15.7%
EPS +19.7%
FCF +29.6%
EBITDA +23.9%
Op. Income —

Compound Growth Rates

Rev CAGR 3Y +9.0%
Rev CAGR 5Y +21.4%
EPS CAGR 3Y +7.6%
EPS CAGR 5Y +24.5%
FCF CAGR 3Y +31.5%
FCF CAGR 5Y +18.3%
EBITDA CAGR 3Y +3.9%
EBITDA CAGR 5Y +22.0%
Payout Ratio
8.68%
Buyback Yield
0.32%
Dividend Yield
0.31%
Total Shareholder Return
-2.09%

Earnings Stability

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1213 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$9.37
Median 1Y
$7.91
5th Pctile
$4.36
95th Pctile
$14.39
Ann. Volatility
36.2%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics
Valuation (12)
MetricValue
Portfolio P/E 51.25
Portfolio P/B 10.68
Portfolio P/S 10.81
EV/EBITDA 34.84
EV/Revenue 10.51
P/FCF 49.05
P/OCF 39.08
PEG 6.78
Earnings Yield 1.95%
FCF Yield 2.04%
OCF Yield 2.56%
Median P/E -4.75
Profitability & Returns (9)
MetricValue
Gross Margin 73.37%
Operating Margin 15.82%
Net Margin 11.07%
FCF Margin 18.17%
ROE 11.32%
ROA 5.34%
ROIC 10.32%
ROCE —
Asset Turnover —
Leverage & Solvency (6)
MetricValue
Debt/Equity 0.63
Debt/Assets 0.29
Net Debt/EBITDA 0.80
Interest Coverage 9.74
Current Ratio 1.86
Quick Ratio 1.56
Efficiency (4)
MetricValue
Asset Turnover —
Inventory Turnover —
Receivables Turnover —
Payables Turnover —
Growth — YoY (6)
MetricValue
Revenue Growth 12.42%
Net Income Growth 15.66%
EPS Growth 19.68%
FCF Growth 29.62%
EBITDA Growth 23.87%
Op. Income Growth —
Growth — CAGR (16)
MetricValue
Revenue CAGR 3Y 8.98%
Revenue CAGR 5Y 21.39%
Revenue CAGR 10Y —
EPS CAGR 3Y 7.56%
EPS CAGR 5Y 24.48%
EPS CAGR 10Y —
FCF CAGR 3Y 31.54%
FCF CAGR 5Y 18.26%
FCF CAGR 10Y —
EBITDA CAGR 3Y 3.94%
EBITDA CAGR 5Y 21.96%
EBITDA CAGR 10Y —
Net Income CAGR 3Y 6.55%
Net Income CAGR 5Y 26.60%
Op. Income CAGR 3Y —
Op. Income CAGR 5Y —
Quality Scores (13)
MetricValue
IS Overall 47.8
IS Profitability 36.1
IS Balance Sheet 50.8
IS Earnings Quality 51.8
IS Growth 50.9
IS Value 35.8
IS Momentum 58.0
IS Safety 87.6
IS Quality 55.0
Altman Z-Score 12.15
Piotroski F-Score 4.71
Beneish M-Score -1.07
Credit Score —
Dividends & Payout (4)
MetricValue
Dividend Yield 0.31%
Payout Ratio 8.68%
Buyback Yield 0.32%
Total Shareholder Return -2.09%
Growth Stability (4)
MetricValue
Revenue Stability 0.718
Earnings Stability 0.305
Earnings Persistence 0.671
Margin Stability 0.692
Medians (3)
MetricValue
Median P/E -4.75
Median P/B 4.00
Median Dividend Yield —
Coverage Meta (3)
MetricValue
Weight Coverage % 99.86%
Holdings Matched 50
Total Holdings —

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms